Literature DB >> 7904414

Psoriasis exacerbation induced by interferon-alpha. Report of two cases.

P Pauluzzi, F Kokelj, V Perkan, G Pozzato, M Moretti.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 7904414     DOI： 10.2340/0001555573395

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  10 in total

Review 1.  Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: a review and analysis of 36 cases.

Authors:  M Afshar; A D Martinez; R L Gallo; T R Hata
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-06-01       Impact factor: 6.166

Review 2.  Immune responses and therapeutic options in psoriasis.

Authors:  Inna S Afonina; Elien Van Nuffel; Rudi Beyaert
Journal:  Cell Mol Life Sci       Date:  2021-01-02       Impact factor: 9.261

Review 3.  Antimicrobial peptides in the pathogenesis of psoriasis.

Authors:  Shin Morizane; Richard L Gallo
Journal:  J Dermatol       Date:  2012-03       Impact factor: 4.005

4.  Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production.

Authors:  Frank O Nestle; Curdin Conrad; Adrian Tun-Kyi; Bernhard Homey; Michael Gombert; Onur Boyman; Günter Burg; Yong-Jun Liu; Michel Gilliet
Journal:  J Exp Med       Date:  2005-07-04       Impact factor: 14.307

Review 5.  Scanning the Immunopathogenesis of Psoriasis.

Authors:  Andrea Chiricozzi; Paolo Romanelli; Elisabetta Volpe; Giovanna Borsellino; Marco Romanelli
Journal:  Int J Mol Sci       Date:  2018-01-08       Impact factor: 5.923

6.  Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new Direct-Acting Antiviral agents.

Authors:  Giovanni Damiani; Chiara Franchi; Paolo Pigatto; Andrea Altomare; Alessia Pacifico; Stephen Petrou; Sebastiano Leone; Maria Caterina Pace; Marco Fiore
Journal:  World J Hepatol       Date:  2018-02-27

7.  A peptide derived from phage-display limits psoriasis-like lesions in mice.

Authors:  L A Zapi-Colín; G Gutiérrez-González; S Rodríguez-Martínez; J C Cancino-Diaz; A Méndez-Tenorio; S M Pérez-Tapia; F Gómez-Chávez; C Cedillo-Peláez; M E Cancino-Diaz
Journal:  Heliyon       Date:  2020-06-17

Review 8.  Psoriasis: Classical vs. Paradoxical. The Yin-Yang of TNF and Type I Interferon.

Authors:  Alessio Mylonas; Curdin Conrad
Journal:  Front Immunol       Date:  2018-11-28       Impact factor: 7.561

9.  Type I interferon: potential therapeutic target for psoriasis?

Authors:  Yihong Yao; Laura Richman; Chris Morehouse; Melissa de los Reyes; Brandon W Higgs; Anmarie Boutrin; Barbara White; Anthony Coyle; James Krueger; Peter A Kiener; Bahija Jallal
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240

10.  Case reports in medical education: a platform for training medical students, residents, and fellows in scientific writing and critical thinking.

Authors:  Aleksandra G Florek; Robert P Dellavalle
Journal:  J Med Case Rep       Date:  2016-04-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.